| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.0000267745.03488.47 |
| P698 | PubMed publication ID | 17446434 |
| P2093 | author name string | Chieko Mineo | |
| Philip W Shaul | |||
| Steven Black | |||
| Sherri Osborne-Lawrence | |||
| Wanpen Vongpatanasin | |||
| R Ann Word | |||
| Weifei Zhu | |||
| David Samols | |||
| Divya Seetharam | |||
| Andrew K Gormley | |||
| Linda L Gibson | |||
| Lisa Hahner | |||
| Randall Schwartz | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1452-1459 | |
| P577 | publication date | 2007-04-19 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice | |
| P478 | volume | 100 |
| Q35089883 | AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats |
| Q34333932 | Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP. |
| Q37035654 | An integrated view of insulin resistance and endothelial dysfunction |
| Q35070716 | Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice |
| Q34986430 | C-Reactive Protein: How Has JUPITER Impacted Clinical Practice? |
| Q36635312 | C-reactive protein causes insulin resistance in mice through Fcγ receptor IIB-mediated inhibition of skeletal muscle glucose delivery |
| Q47369620 | C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study. |
| Q37408109 | C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling |
| Q37245114 | C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: role of peroxynitrite |
| Q37422600 | C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction |
| Q37323477 | C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. |
| Q85639237 | C-reactive protein reduces protein S-nitrosylation in endothelial cells |
| Q35547019 | Coupling of Fcγ receptor I to Fcγ receptor IIb by SRC kinase mediates C-reactive protein impairment of endothelial function |
| Q41501004 | Downregulation of autophagy is associated with severe ischemia-reperfusion-induced acute kidney injury in overexpressing C-reactive protein mice. |
| Q36484973 | Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein |
| Q27021449 | Fcγ receptors and ligands and cardiovascular disease |
| Q39954815 | G-CSF exerts dual effects on endothelial cells--opposing actions of direct eNOS induction versus indirect CRP elevation. |
| Q34066540 | Human C-reactive protein and the metabolic syndrome |
| Q35606603 | PDZK1 prevents neointima formation via suppression of breakpoint cluster region kinase in vascular smooth muscle |
| Q54654762 | Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid–induced endothelial dysfunction |
| Q33788524 | Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome |
| Q35920339 | Role of interferon alpha in endothelial dysfunction: insights into endothelial nitric oxide synthase-related mechanisms |
| Q40253613 | Role of the endothelium in the metabolic syndrome: IIB or not IIB. |
| Q33702090 | Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein. |
| Q24594814 | Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective |
| Q37144130 | The evolving role of C-reactive protein in atherothrombosis |
| Q35106315 | Vascular biology of metabolic syndrome |
Search more.